Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
Abstract Although ASXL1 mutations are frequently found in human diseases, including myeloid leukemia, the cell proliferation–associated function of ASXL1 is largely unknown. Here, we explored the molecular mechanism underlying the growth defect found in Asxl1-deficient mouse embryonic fibroblasts (M...
Guardado en:
Autores principales: | Hye Sook Youn, Tae-Yoon Kim, Ui-Hyun Park, Seung-Tae Moon, So-Jung An, Yong-Kyu Lee, Jin-Taek Hwang, Eun-Joo Kim, Soo-Jong Um |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aeedf74d7e724fa6bb3f01a2f6594b3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of Asxl2 leads to myeloid malignancies in mice
por: Jianping Li, et al.
Publicado: (2017) -
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Yi Bao, et al.
Publicado: (2020) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
por: Jean-Baptiste Micol, et al.
Publicado: (2017) -
EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Julian C. Lui, et al.
Publicado: (2016) -
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Danny D. Sahtoe, et al.
Publicado: (2016)